FDA grants meeting on Avastin for breast cancer

February 24, 2011 4:46:06 PM PST
The Food and Drug Administration has granted Swiss drugmaker Roche a first-of-a-kind public hearing to defend the effectiveness of its drug Avastin for treating breast cancer, just months after the agency ruled that the drug is ineffective for that use.